Management of Immune-Related Adverse Events in Patients Treated with Immuno Oncology Agents

Register via the following link: https://www.medlearninggroup.com/cme-programming/acep-ma PROGRAM FEATURES

• Virtual Reality videos included in presentation
• Case-based learning environment
• iPads provided to enhance learning experience
• Personalized poster portal

FACULTY

Shayma Master Kazmi, MD, RPh Medical Lead of Advanced Oncology, Oncology/Hematology Comprehensive Care and Research Center Philadelphia, PA

TARGET AUDIENCE

This programming is designed to meet the educational needs of Emergency-department physicians and other healthcare professionals working as part of the multidisciplinary care team.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the effects of ICI therapy on immune system cells that lead to IrAEs in patients with cancer seen by emergency physicians
• Describe the role of emergency physicians in the recognition of signs and symptoms of ICI IrAEs and their management in patients with cancer
• Review strategies to overcome barriers to the implementation of necessary practice changes for emergency physicians seeing cancer patients with ICI IrAE